(-)-[3H]Desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: Differentiation by temperature and dihydropyridines

Research output: Contribution to journalArticle

Abstract

The verapamil-like calcium channel modulator, (-)-[3H]desmethoxyverapamil binds to multiple sites in microsomal membrane preparations from brain and skeletal muscle. In brain the K(d) values of the sites are 0.55 ± 0.1 and 61.8 ± 18 nM for the high and low affinity sites and the maximum binding values are 0.22 ± 0.04 and 4.6 ± 1.0 pmol/mg of protein, respectively. Equilibrium analysis of saturation data in skeletal muscle membranes shows only one site with an affinity of 7.2 ± 0.8 nM and a maximum binding of 2.96 ± 0.32 pmol/mg of protein. However, a low affinity site with an estimated K(d) of 152 nM is indicated in dissociation kinetic studies. Dihydropyridine calcium channel modulators regulate the binding of desmethoxyverapamil in a temperature-dependent fashion with (+)-PN 200110 decreasing (-)-[3H]desmethoxyverapamil binding more at 0°C than at higher temperatures and, at 37° C, enhancing binding in skeletal muscle. The influence of (+)-desmethoxyverapamil on (+)-[3H]PN 200110 binding is unchanged by temperature variations, whereas interactions of the (-)-enantiomer are altered markedly with more inhibition at 0°C than at higher temperatures and, in skeletal muscle, stimulation of binding at 37° C. Dissociation studies indicate that the two sites labeled by (-)-[3H]-desmethoxyverapamil in skeletal muscle interact in a negative heterotropic cooperative fashion. Dihydropyridines appear to slow the dissociation of ligand from the low affinity site, whereas diltiazem accelerates the dissociation of (-)-[3H]desmethoxyverapamil from the high affinity site. These results suggest that the high and low affinity sites labeled by (-)-[3H]desmethoxyverapamil, respectively, represent the verapamil and diltiazem receptors in brain and skeletal muscle.

LanguageEnglish (US)
Pages731-738
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume237
Issue number3
StatePublished - 1986

Fingerprint

Dihydropyridines
Calcium Channels
Skeletal Muscle
Temperature
Membranes
Brain
Diltiazem
Verapamil
Proteins
Binding Sites
Ligands

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{64f88d14227a4375b1b215a9c0075073,
title = "(-)-[3H]Desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: Differentiation by temperature and dihydropyridines",
abstract = "The verapamil-like calcium channel modulator, (-)-[3H]desmethoxyverapamil binds to multiple sites in microsomal membrane preparations from brain and skeletal muscle. In brain the K(d) values of the sites are 0.55 ± 0.1 and 61.8 ± 18 nM for the high and low affinity sites and the maximum binding values are 0.22 ± 0.04 and 4.6 ± 1.0 pmol/mg of protein, respectively. Equilibrium analysis of saturation data in skeletal muscle membranes shows only one site with an affinity of 7.2 ± 0.8 nM and a maximum binding of 2.96 ± 0.32 pmol/mg of protein. However, a low affinity site with an estimated K(d) of 152 nM is indicated in dissociation kinetic studies. Dihydropyridine calcium channel modulators regulate the binding of desmethoxyverapamil in a temperature-dependent fashion with (+)-PN 200110 decreasing (-)-[3H]desmethoxyverapamil binding more at 0°C than at higher temperatures and, at 37° C, enhancing binding in skeletal muscle. The influence of (+)-desmethoxyverapamil on (+)-[3H]PN 200110 binding is unchanged by temperature variations, whereas interactions of the (-)-enantiomer are altered markedly with more inhibition at 0°C than at higher temperatures and, in skeletal muscle, stimulation of binding at 37° C. Dissociation studies indicate that the two sites labeled by (-)-[3H]-desmethoxyverapamil in skeletal muscle interact in a negative heterotropic cooperative fashion. Dihydropyridines appear to slow the dissociation of ligand from the low affinity site, whereas diltiazem accelerates the dissociation of (-)-[3H]desmethoxyverapamil from the high affinity site. These results suggest that the high and low affinity sites labeled by (-)-[3H]desmethoxyverapamil, respectively, represent the verapamil and diltiazem receptors in brain and skeletal muscle.",
author = "Reynolds, {I. J.} and Snowman, {Adele M} and Snyder, {Solomon H}",
year = "1986",
language = "English (US)",
volume = "237",
pages = "731--738",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - (-)-[3H]Desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes

T2 - Journal of Pharmacology and Experimental Therapeutics

AU - Reynolds, I. J.

AU - Snowman, Adele M

AU - Snyder, Solomon H

PY - 1986

Y1 - 1986

N2 - The verapamil-like calcium channel modulator, (-)-[3H]desmethoxyverapamil binds to multiple sites in microsomal membrane preparations from brain and skeletal muscle. In brain the K(d) values of the sites are 0.55 ± 0.1 and 61.8 ± 18 nM for the high and low affinity sites and the maximum binding values are 0.22 ± 0.04 and 4.6 ± 1.0 pmol/mg of protein, respectively. Equilibrium analysis of saturation data in skeletal muscle membranes shows only one site with an affinity of 7.2 ± 0.8 nM and a maximum binding of 2.96 ± 0.32 pmol/mg of protein. However, a low affinity site with an estimated K(d) of 152 nM is indicated in dissociation kinetic studies. Dihydropyridine calcium channel modulators regulate the binding of desmethoxyverapamil in a temperature-dependent fashion with (+)-PN 200110 decreasing (-)-[3H]desmethoxyverapamil binding more at 0°C than at higher temperatures and, at 37° C, enhancing binding in skeletal muscle. The influence of (+)-desmethoxyverapamil on (+)-[3H]PN 200110 binding is unchanged by temperature variations, whereas interactions of the (-)-enantiomer are altered markedly with more inhibition at 0°C than at higher temperatures and, in skeletal muscle, stimulation of binding at 37° C. Dissociation studies indicate that the two sites labeled by (-)-[3H]-desmethoxyverapamil in skeletal muscle interact in a negative heterotropic cooperative fashion. Dihydropyridines appear to slow the dissociation of ligand from the low affinity site, whereas diltiazem accelerates the dissociation of (-)-[3H]desmethoxyverapamil from the high affinity site. These results suggest that the high and low affinity sites labeled by (-)-[3H]desmethoxyverapamil, respectively, represent the verapamil and diltiazem receptors in brain and skeletal muscle.

AB - The verapamil-like calcium channel modulator, (-)-[3H]desmethoxyverapamil binds to multiple sites in microsomal membrane preparations from brain and skeletal muscle. In brain the K(d) values of the sites are 0.55 ± 0.1 and 61.8 ± 18 nM for the high and low affinity sites and the maximum binding values are 0.22 ± 0.04 and 4.6 ± 1.0 pmol/mg of protein, respectively. Equilibrium analysis of saturation data in skeletal muscle membranes shows only one site with an affinity of 7.2 ± 0.8 nM and a maximum binding of 2.96 ± 0.32 pmol/mg of protein. However, a low affinity site with an estimated K(d) of 152 nM is indicated in dissociation kinetic studies. Dihydropyridine calcium channel modulators regulate the binding of desmethoxyverapamil in a temperature-dependent fashion with (+)-PN 200110 decreasing (-)-[3H]desmethoxyverapamil binding more at 0°C than at higher temperatures and, at 37° C, enhancing binding in skeletal muscle. The influence of (+)-desmethoxyverapamil on (+)-[3H]PN 200110 binding is unchanged by temperature variations, whereas interactions of the (-)-enantiomer are altered markedly with more inhibition at 0°C than at higher temperatures and, in skeletal muscle, stimulation of binding at 37° C. Dissociation studies indicate that the two sites labeled by (-)-[3H]-desmethoxyverapamil in skeletal muscle interact in a negative heterotropic cooperative fashion. Dihydropyridines appear to slow the dissociation of ligand from the low affinity site, whereas diltiazem accelerates the dissociation of (-)-[3H]desmethoxyverapamil from the high affinity site. These results suggest that the high and low affinity sites labeled by (-)-[3H]desmethoxyverapamil, respectively, represent the verapamil and diltiazem receptors in brain and skeletal muscle.

UR - http://www.scopus.com/inward/record.url?scp=0022559089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022559089&partnerID=8YFLogxK

M3 - Article

VL - 237

SP - 731

EP - 738

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -